CN Patent

CN101594871B — 吡咯并嘧啶化合物及其用途

Assigned to Novartis AG · Expires 2013-06-19 · 13y expired

What this patent protects

本申请描述了可用于治疗、预防和/或改善疾病的有机化合物，具体而言，描述了抑制蛋白激酶的吡咯并嘧啶化合物及衍生物。该有机化合物可用于治疗增殖性疾病。

USPTO Abstract

本申请描述了可用于治疗、预防和/或改善疾病的有机化合物，具体而言，描述了抑制蛋白激酶的吡咯并嘧啶化合物及衍生物。该有机化合物可用于治疗增殖性疾病。

Drugs covered by this patent

Patent Metadata

Patent number
CN101594871B
Jurisdiction
CN
Classification
—
Expires
2013-06-19
Drug substance claim
No
Drug product claim
No
Assignee
Novartis AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.